CombiMatrix Shareholders Approve Second Tranche of Private Placement, Reverse Stock Split | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix announced after the close of the market on Tuesday that shareholders approved the second tranche of a private placement that seeks to raise $2.5 million in total.

Shareholders also approved a one-for-10 reverse stock split, the Irvine, Calif.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.